Tinea Pedis: Dermatological pruritic lesion in the feet, caused by Trichophyton rubrum, T. mentagrophytes, or Epidermophyton floccosum.Tinea: Fungal infection of keratinized tissues such as hair, skin and nails. The main causative fungi include MICROSPORUM; TRICHOPHYTON; and EPIDERMOPHYTON.Trichophyton: A mitosporic fungal genus and an anamorphic form of Arthroderma. Various species attack the skin, nails, and hair.Onychomycosis: A fungal infection of the nail, usually caused by DERMATOPHYTES; YEASTS; or nondermatophyte MOLDS.Tinea Versicolor: A common chronic, noninflammatory and usually symptomless disorder, characterized by the occurrence of multiple macular patches of all sizes and shapes, and varying in pigmentation from fawn-colored to brown. It is seen most frequently in hot, humid, tropical regions, and is caused by Pityrosporon orbiculare. (Dorland, 27th ed)Epidermophyton: A fungal genus which grows in the epidermis and is the cause of TINEA.Tinea Capitis: Ringworm of the scalp and associated hair mainly caused by species of MICROSPORUM; TRICHOPHYTON; and EPIDERMOPHYTON, which may occasionally involve the eyebrows and eyelashes.Dermatomycoses: Superficial infections of the skin or its appendages by any of various fungi.Foot Dermatoses: Skin diseases of the foot, general or unspecified.Candidiasis, Cutaneous: Candidiasis of the skin manifested as eczema-like lesions of the interdigital spaces, perleche, or chronic paronychia. (Dorland, 27th ed)Arthrodermataceae: A family of ascomycetous fungi, order Onygenales, characterized by smooth ascospores. Genera in the family include Arthroderma, Keratinomyces, and Ctenomyces. Several well-known anamorphic forms are parasitic upon the skin.Tolnaftate: A synthetic antifungal agent.Tinea Favosa: A disease of the scalp that may affect the glabrous skin and the nails and is recognized by the concave sulfur-yellow crusts that form around loose, wiry hairs. Atrophy ensues, leaving a smooth, glossy, thin, paper-white patch. This type of disease is rare in the United States and more frequently seen in the Middle East, Africa, Southeastern Europe, and other countries bordering the Mediterranean Sea. (Arnold, Odom, and James, Andrew's Diseases of the Skin, 8th ed, p319)Griseofulvin: An antifungal agent used in the treatment of TINEA infections.Antifungal Agents: Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues.Microsporum: A mitosporic Oxygenales fungal genus causing various diseases of the skin and hair. The species Microsporum canis produces TINEA CAPITIS and tinea corporis, which usually are acquired from domestic cats and dogs. Teleomorphs includes Arthroderma (Nannizzia). (Alexopoulos et al., Introductory Mycology, 4th edition, p305)

*  Tinea Pedis: Background, Pathophysiology, Epidemiology
The first report of tinea pedis was in 1908 by Whitfield, who, with Sabouraud, believed that tinea pedis was a very rare ... Tinea pedis has afflicted humanity for centuries, so it is perhaps surprising that the condition was not described until ... infection caused by the same organisms that produce tinea capitis. ... Other Medscape tinea articles include Tinea Barbae, Tinea Capitis, Tinea Corporis, Tinea Cruris, Tinea Faciei, Tinea Nigra, and ...
  https://emedicine.medscape.com/article/1091684-overview
*  Athlete's Foot (Tinea Pedis) in Adults: Condition, Treatments, and Pictures - Overview | skinsight
Another type of tinea pedis infection, called bullous tinea pedis, has painful and itchy blisters on the arch (instep) and/or ... The most severe form of tinea pedis infection, called ulcerative tinea pedis, appears as painful blisters, pus-filled bumps ( ... Athlete's foot (tinea pedis), also known as ringworm of the foot, is a surface (superficial) fungal infection of the skin of ... Ulcerative tinea pedis occurs most frequently in people with diabetes and others with weak immune systems. ...
  https://www.skinsight.com/skin-conditions/adult/tinea-pedis-athletes-foot
*  Pediatric Fungal Infections
Whereas tinea pedis and tinea cruris are more common in postpubertal patients, tinea corporis is more common in those who are ... Patients who already have tinea pedis or tinea cruris are more likely to develop tinea corporis, as the fungi spread to any ... Tinea Corporis. Tinea corporis is also known as tinea circinata or "ringworm" of the body.1 It is one of a group of fungal ... as tinea infections in these locations are given other designations (e.g., tinea pedis, capitis, cruris, and manuum). The fungi ...
  https://www.uspharmacist.com/article/pediatric-fungal-infections
*  IBIMA Publishing A Case of Tinea Pedis Caused by Trichophyton Tonsurans
We here present a case of tinea pedis with an unusual aetiological pathogen: Trichophyton tonsurans. ... Tinea infections are very common skin disorders caused by dermatophytes that have the unique ability to invade tissue ... Cite this Article as: B.C. Carlsen and T. Menné (2013), "A Case of Tinea Pedis Caused by Trichophyton Tonsurans," International ... A Case of Tinea Pedis Caused by Trichophyton Tonsurans. International Journal of Veterinary Medicine: Research & Reports. ...
  http://ibimapublishing.com/articles/IJVMR/2013/204515/
*  The 2016 Report on Tinea Pedis (Athlete's Foot) Drugs: World Market Segmentation by City
World Market Segmentation by City The 2016 Report on Tinea Pedis (Athlete's Foot) Drugs: World Market - Market research report ... The 2016 Report on Tinea Pedis (Athlete's Foot) Drugs: ... The 2016 Report on Tinea Pedis (Athlete's Foot) Drugs: World ... The 2016 Report on Tinea Pedis (Athlete's Foot) Drugs: World Market Segmentation by City. Lowest Prices Guaranteed. Length. ... In what follows, I summarize the economic potential for the world's major cities for "Tinea Pedis (Athlete's Foot) drugs" for ...
  https://www.marketresearch.com/Icon-Group-International-Inc-v609/Tinea-Pedis-Athlete-Foot-Drugs-9226034/
*  Tinea Pedis - Blacktown Podiatry
The treatment for tinea pedis will be determined by the type and severity of tinea you have. It is best to seek advice from ... Tinea pedis (tinea of the feet) is one of the most common fungal infections of the skin. It is rare before puberty. It may last ... Tinea pedis can be seen in three different areas of the feet and present differently in each:. *Interdigital: ("Athlete's Foot ... Vesicular: is the least common type of tinea pedis with little blisters commonly on the arch or sole of the foot. Often redness ...
  http://blacktownpodiatry.com.au/knowledge-base/tinea-pedis/
*  Treating Tinea Pedis In Patients With Diabetes | Podiatry Today
Accordingly, these authors provide a closer look at treatment and prevention strategies for tinea pedis, which often occurs in ... Patients with diabetes face a higher risk of tinea pedis, which can lead to complications, and research is scarce on the ... Patients with diabetes face a higher risk of tinea pedis, which can lead to complications, and research is scarce on the ... For further reading, see "A Closer Look At Topicals For Tinea Pedis" in the September 2009 issue of Podiatry Today, "Addressing ...
  https://www.podiatrytoday.com/treating-tinea-pedis-patients-diabetes?page=1
*  Athlete's Foot (Tinea Pedis) Clinical Research Trials | CenterWatch
Tinea Pedis) Clinical Research Trial Listings in Dermatology Family Medicine Infections and Infectious Diseases Podiatry on ... Athlete's Foot (Tinea Pedis) Clinical Trials. A listing of Athlete's Foot (Tinea Pedis) medical research trials actively ... Study Evaluating the Drug Interaction Potential of Luliconazole Cream 1% in Subjects With Tinea Pedis and Tinea Cruris ... Infections due to the dermatophytes are termed dermatophytosis or tinea. Tinea pedis ... ...
  https://www.centerwatch.com/clinical-trials/listings/condition/190/athletes-foot-tinea-pedis/?&gender=Both
*  Ecoza User Reviews for Tinea Pedis at Drugs.com
Reviews and ratings for ecoza when used in the treatment of tinea pedis. Share your experience with this medication by writing ... Tinea Pedis clotrimazole topical, ketoconazole topical, Lotrisone, terbinafine topical, Lamisil, miconazole topical, ciclopirox ... Reviews for Ecoza to treat Tinea Pedis. No reviews have yet been submitted. Be the first to review this drug. ...
  https://www.drugs.com/comments/econazole-topical/ecoza-for-tinea-pedis.html
*  Efficacy and Safety of LAS41003 in the Treatment of Inflammatory Tinea Pedis - Full Text View - ClinicalTrials.gov
Tinea. Tinea Pedis. Dermatomycoses. Skin Diseases, Infectious. Infection. Mycoses. Skin Diseases. Foot Dermatoses. Foot ... Efficacy and Safety of LAS41003 in the Treatment of Inflammatory Tinea Pedis. The safety and scientific validity of this study ... presence of tinea pedis caused by dermatophytes on one or both feet, characterized by physician's global assessment score of 2 ... patients with hyperkeratotic chronic plantar tinea pedis (moccasin type);. *receiving systemic therapy with cytotoxic or ...
  https://clinicaltrials.gov/ct2/show/NCT01096472
*  Close-up of athlete's foot Tinea pedis infection - Stock Image M270/0145 - Science Photo Library
This condition, also called tinea pedis, is the most common form of ringworm, a fungal infection on the surface of the skin. It ... This condition, also called tinea pedis, is the most common form of ringworm, a fungal infection on the surface of the skin. It ... Close-up of athlete's foot Tinea pedis infection. M270/0145 Rights Managed ...
  http://www.sciencephoto.com/media/262824/view
*  Image: Scaling of the Entire Sole in Athlete's Foot (Tinea Pedis) - Merck Manuals Consumer Version
Merck & Co., Inc., Kenilworth, NJ, USA is a global healthcare leader working to help the world be well. From developing new therapies that treat and prevent disease to helping people in need, we are committed to improving health and well-being around the world. The Merck Manual was first published in 1899 as a service to the community. The legacy of this great resource continues as the Merck Manual in the US and Canada and the MSD Manual in the remainder of the world. Learn more about our commitment to Global Medical Knowledge.. ...
  http://www.merckmanuals.com/en-ca/home/multimedia/image/v28487606
*  Safety of a Topical Antifungal Treatment for Tinea Cruris, Tinea Pedis and Tinea Corporis - Full Text View - ClinicalTrials.gov
Safety of a Topical Antifungal Treatment for Tinea Cruris, Tinea Pedis and Tinea Corporis. The safety and scientific validity ... To examine the long-term safety of treating tinea pedis, tinea corporis or tinea cruris, treatment-emergent adverse events ... Evidence of tinea cruris, tinea pedis, or tinea corporis. Additional criteria listed in protocol ... Tinea. Tinea Pedis. Dermatomycoses. Skin Diseases, Infectious. Infection. Mycoses. Skin Diseases. Foot Dermatoses. Foot ...
  https://clinicaltrials.gov/ct2/show/NCT01349998?recr=Open&cond=%22Tinea%22&rank=1
*  Evaluate the Clinical Equivalence of Two Naftifine HCl 1% Creams in Patients With Interdigital Tinea Pedis - Full Text View -...
Tinea. Tinea Pedis. Dermatomycoses. Skin Diseases, Infectious. Infection. Mycoses. Skin Diseases. Foot Dermatoses. Foot ... Tinea Pedis Drug: Naftifine HCl Cream 1% Drug: Naftin® (Naftifine HCl) Cream 1% Drug: Placebo topical cream Phase 1 ... Evaluate the Clinical Equivalence of Two Naftifine HCl 1% Creams in Patients With Interdigital Tinea Pedis. The safety and ... A total score of at least 4 for the clinical signs and symptoms of tinea pedis for the target lesion. In addition, the most ...
  https://clinicaltrials.gov/ct2/show/study/NCT01580891?show_locs=Y
*  A Study to Evaluate Efficacy and Safety of Three W0027 Regimens in the Treatment of Moccasin Type Tinea Pedis (MTTP) - Full...
Tinea. Tinea Pedis. Dermatomycoses. Skin Diseases, Infectious. Infection. Mycoses. Skin Diseases. Foot Dermatoses. Foot ... A Study to Evaluate Efficacy and Safety of Three W0027 Regimens in the Treatment of Moccasin Type Tinea Pedis (MTTP). The ... Subjects aged 18-65 years, who have been diagnosed with moccasin type tinea pedis (by positive dermatophyte culture, positive ... 120 subjects with moccasin type tinea pedis (MTTP) will be enrolled at approximately 11 centres in the USA, Canada and ...
  https://clinicaltrials.gov/ct2/show/NCT00509275
*  What is the cause and treatment for Tinea Pedis?
... Ask a Doctor about uses, dosages and side-effects of Clotrimazole, Ask a ... Brief Answer: Tinea Pedis Detailed Answer: Hi. Thanks for posting your concern at HCM I would keep a possibility of Tinea Pedis ... Bullous tinea pedis treatment. *What is the cause and treatment for tinea pedis ... Chronic tinea pedis treatment. *Interdigital tinea pedis treatments. * ...
  http://www.healthcaremagic.com/premiumquestions/What-is-the-cause-and-treatment-for-Tinea-Pedis/91540
*  Ringworm (Tinea) - Health911.com - tinea versicolor, tinea, tinea capitis, tinea pedis, tinea corporis, tinea cruris, ringworm...
... tinea, tinea capitis, tinea pedis, tinea corporis, tinea cruris, ringworm tinea, tinea ringworm, tinea versicolor treatment, ... Scalp ringworm is also called tinea capitis. As a rule, fungi will only infect the scalps of preadolescents. This is because at ... Patchy areas of hair loss containing broken, fragmented hairs characterize tinea capitis. In more severe cases, these areas may ... Tinea corporis may be spread by contact with pets and someone already infected. ...
  http://www.health911.com/ringworm-
*  Athlete's Foot (Tinea Pedis)
Athlete's Foot, also known as tinea pedis, is a skin disease caused by a fungus that usually occurs between the toes. The ...
  http://www.320-foot.com/library/3768/Athlete%27sFoot%28TineaPedis%29.html
*  BlablaDoctor - Group Profile - Tinea Pedis
Tinea Pedis is a fungal infection of the skin that causes scaling, flaking, and itch of affected areas. It is caused by fungi ... Description: Tinea Pedis is a fungal infection of the skin that causes scaling, flaking, and itch of affected areas. It is ... Transport posted a new discussion topic in the group Tinea Pedis: Jamur Pada Jari-Jari Kaki ... andry posted a new discussion topic in the group Tinea Pedis: hitam dan mengeluarkan lendir ...
  http://blabladoctor.com/group/tinea-pedis
*  What Is Microbiology - Progressive Multifocal Leukoencephalopathy - Medicalrealm
What Is Dermatology - Tinea Pedis * What Is Dermatology - Mammary Paget Disease * What Is Dermatology - Epidermolysis Bullosa ...
  http://www.medicalrealm.net/what-is-microbiology---progressive-multifocal-leukoencephalopathy1.html
*  Patient Education - Chicago, IL | Foot Doctor
Athlete's Foot (Tinea Pedis). *Fungal Nails. *Heel Problems*Haglund's Deformity. *Heel Callus ...
  http://www.myachingfoot.com/education.html?query=Plantar+Fasciitis
*  Warts - Tyler, TX | Podiatrist
Athlete's Foot (Tinea Pedis). *Fungal Nails. *Heel Problems *Haglund's Deformity. *Heel Callus ...
  https://www.tylerfootclinic.com/library/1957/Warts.html
*  Total N00b friendly Method] Making $5.5k a month from Movie Streaming website [Zero
Tinea pedis, cruris, & corpora Dose: Pts 17 y discount kamagra effervescent 100mg mastercard erectile dysfunction treatment in ...
  http://bitshacking.ru/showthread.php?tid=682&pid=161264
*  Sertaconazole (Topical route)
Sertaconazole is applied to your skin to treat athlete's foot (tinea pedis). ...
  https://www.allinahealth.org/CCS/doc/Thomson%20Detailed%20Drugs/47/601229.htm

(1/41) Management and morbidity of cellulitis of the leg.

Ascending cellulitis of the leg is a common emergency. An audit was conducted in two district general hospitals to determine how it is managed and the long-term morbidity, and to formulate a treatment strategy. Case notes were reviewed for 92 patients admitted to hospital under adult specialties. Mean duration of inpatient therapy was 10 days. A likely portal of entry was identified in 51/92 cases, of which the commonest were minor injuries and tinea pedis. Pathogens were rarely identified, group G streptococci being the single most frequent organism. Benzylpenicillin was administered in only 43 cases. Long-term morbidity, identified in 8 of 70 patients with over six months' follow-up, included persistent oedema (6) and leg ulceration (2); an additional 19 patients had either suffered previous episodes or experienced a further episode subsequently. Ascending cellulitis of the leg has substantial short-term and long-term morbidity. Important but often neglected therapeutic suggestions are the inclusion of benzylpenicillin in all cases without a contraindication, assessment and treatment of tinea pedis, use of support hosiery, and serological testing for streptococci to confirm the diagnosis in retrospect. The high frequency of recurrent episodes suggests that longer courses of penicillin, or penicillin prophylaxis, might be useful.  (+info)

(2/41) Prevalence and risk factors of tinea unguium and tinea pedis in the general population in Spain.

This study prospectively evaluated the prevalence and risk factors of tinea unguium and tinea pedis in the general adult population in Madrid, Spain. One thousand subjects were clinically examined, and samples of nails and scales from the interdigital spaces of the feet were taken from those patients presenting with signs or symptoms of onychomycosis and/or tinea pedis, respectively. In addition, a sample from the fourth interdigital space of both feet was collected from all individuals with a piece of sterilized wool carpet. Tinea unguium was defined as a positive direct examination with potassium hydroxide and culture of the etiological agent from subjects with clinically abnormal nails. Patients with positive dermatophyte cultures of foot specimens were considered to have tinea pedis. The prevalence of tinea unguium was 2.8% (4.0% for men and 1.7% for women), and the prevalence of tinea pedis was 2.9% (4.2% for men and 1.7% for women). The etiological agents of tinea unguium were identified as Trichopyton rubrum (82.1%), followed by Trichopyton mentagrophytes var. interdigitale (14.3%) and Trichopyton tonsurans (3.5%). Trichophyton rubrum (44.8%) and Trichophyton mentagrophytes (44.8%), followed by Epidermophyton floccosum (7%) and T. tonsurans (3.4%), were the organisms isolated from patients with tinea pedis. The percentage of subjects who suffered simultaneously from both diseases was 1.1% (1.7% for men and 0.6% for women). In a multivariate logistic regression analysis, age (relative risk [RR], 1.03) and gender (RR, 2.50) were independent risk factors for tinea unguium, while only gender (RR, 2.65) was predictive for the occurrence of tinea pedis. In both analyses, the presence of one of the two conditions was associated with a higher risk for the appearance of the other disease (RR, >25).  (+info)

(3/41) Lactoferrin given in food facilitates dermatophytosis cure in guinea pig models.

Dermatophytosis is the most common skin infection caused by dermatophytic fungi, such as Trichophyton spp. We studied the in vitro and in vivo antifungal effects of lactoferrin against Trichophyton. Human and bovine lactoferrin, and a bovine lactoferrin-derived peptide, lactoferricin B, showed in vitro antifungal activity that was dependent on the test strain and medium used. In guinea pigs infected on the back with Trichophyton mentagrophytes (i.e. those with tinea corporis), consecutive daily po administration of bovine lactoferrin did not prevent development of symptoms during the early phase of infection, but facilitated clinical improvement of skin lesions after the peak of the symptoms. The fungal burden in lesions was less in guinea pigs that had been given lactoferrin than in untreated controls 21 days after infection. In guinea pigs infected on the foot with T. mentagrophytes (i.e. those with tinea pedis), the fungal burden of the skin on the heel portion of the infected foot 35 days after infection was lower in animals fed lactoferrin than in controls. These results suggest the potential usefulness of lactoferrin as a food component for promoting dermatophytosis cure.  (+info)

(4/41) In vitro antifungal activity of KP-103, a novel triazole derivative, and its therapeutic efficacy against experimental plantar tinea pedis and cutaneous candidiasis in guinea pigs.

The in vitro activity of KP-103, a novel triazole derivative, against pathogenic fungi that cause dermatomycoses and its therapeutic efficacy against plantar tinea pedis and cutaneous candidiasis in guinea pigs were investigated. MICs were determined by a broth microdilution method with morpholinepropanesulfonic acid-buffered RPMI 1640 medium for Candida species and with Sabouraud dextrose broth for dermatophytes and by an agar dilution method with medium C for Malassezia furfur. KP-103 was the most active of all the drugs tested against Candida albicans (geometric mean [GM] MIC, 0.002 microg/ml), other Candida species including Candida parapsilosis and Candida glabrata (GM MICs, 0.0039 to 0.0442 microg/ml), and M. furfur (GM MIC, 0.025 microg/ml). KP-103 (1% solution) was highly effective as a treatment for guinea pigs with cutaneous candidiasis and achieved mycological eradication in 8 of the 10 infected animals, whereas none of the imidazoles tested (1% solutions) was effective in even reducing the levels of the infecting fungi. KP-103 was as active as clotrimazole and neticonazole but was less active than lanoconazole and butenafine against Trichophyton rubrum (MIC at which 80% of isolates are inhibited [MIC(80)], 0.125 microg/ml) and Trichophyton mentagrophytes (MIC(80), 0.25 microg/ml). However, KP-103 (1% solution) exerted therapeutic efficacy superior to that of neticonazole and comparable to those of lanoconazole and butenafine, yielding negative cultures for all samples from guinea pigs with plantar tinea pedis tested. This suggests that KP-103 has better pharmacokinetic properties in skin tissue than the reference drugs. Because the in vitro activity of KP-103, unlike those of the reference drugs, against T. mentagrophytes was not affected by hair as a keratinic substance, its excellent therapeutic efficacy seems to be attributable to good retention of its antifungal activity in skin tissue, in addition to its potency.  (+info)

(5/41) A prospective epidemiological study on tinea pedis and onychomycosis in Hong Kong.

OBJECTIVE: To study the epidemiology of foot diseases, including tinea pedis and onychomycosis in clinic attendees in Hong Kong. METHODS: Two groups were included: the institutional group consisted of clinical evaluation and mycological investigations by dermatologists; and the private group consisted of clinical evaluation only by the private physicians. Patients who had a regular visit to the clinics were randomly invited to have a clinical examination of their feet. RESULTS: A total of 1014 patients were studied. The prevalence rate of foot disease, fungal infections, tinea pedis and toe nail onychomycosis were respectively 50.7%, 26.9%, 20.4% and 16.6%. More male and elderly patients were affected except that the sex prevalence in toe nail onychomycosis was not shown to be significant. Vascular disease, diabetes mellitus and obesity were the three most prevalent predisposing factors in foot disease, fungal disease and fungal nail disease. Dermatophytes, in particular Trichophyton rubrum, were shown to be the most common pathogen in both skin and nail infections. CONCLUSIONS: Foot diseases, especially tinea pedis and toe nail onychomycosis, are common in patients attending local clinics in Hong Kong. Both physicians and patients should be more aware of foot problems and have more active approaches and management strategies.  (+info)

(6/41) Therapeutic efficacy of topically applied KP-103 against experimental tinea unguium in guinea pigs in comparison with amorolfine and terbinafine.

The therapeutic efficacy of KP-103, a novel topical triazole, in a guinea pig tinea unguium model was investigated. Experimental tinea unguium and tinea pedis were produced by inoculation of Trichophyton mentagrophytes SM-110 between the toes of the hind paw of guinea pigs. One percent solution (0.1 ml) of KP-103, amorolfine, or terbinafine was topically applied to the nails and whole sole of an infected foot once daily for 30 consecutive days, and terbinafine was also orally administered at a daily dose of 40 mg/kg of body weight for 30 consecutive days, starting on day 60 postinfection. The fungal burdens of nails and plantar skin were assessed using a new method, which makes it possible to recover infecting fungi by removing a carryover of the drug remaining in the treated tissues into the culture medium. Topically applied KP-103 inhibited the development of nail collapse, significantly reduced the fungal burden of the nails, and sterilized the infected plantar skin. On the other hand, topical amorolfine and topical or oral terbinafine were ineffective for tinea unguium, although these drugs eradicated or reduced the fungal burden of plantar skin. The in vitro activities of amorolfine and terbinafine against T. mentagrophytes SM-110 were 8- and 32-fold, respectively, decreased by the addition of 5% keratin to Sabouraud dextrose broth medium. In contrast, the activity of KP-103 was not affected by keratin because its keratin affinity is lower than those of the reference drugs, suggesting that KP-103 largely exists in the nails as an active form that was not bound to keratin and diffuses in the nail without being trapped by keratin. The effectiveness of KP-103 against tinea unguium is probably due to its favorable pharmacokinetic properties in the nails together with its potent antifungal activity.  (+info)

(7/41) Skin disease among staff in a large Korean nursing home.

Although previous studies have documented reasonably high rates of skin disease among nursing home staff, the prevalence among Korean workers is not well known. For this investigation we selected a large Korean nursing home and distributed a skin disease questionnaire to all staff. Questions included job title, job description, employment history, working hours, patient contact and the occurrence of skin disease over the past 12 months. Workers who reported a dermatological problem then underwent skin examinations conducted by specialist occupational physicians and a dermatologist. Contact dermatitis was the most common skin disease detected, with 4.8% of staff currently suffering from it and 6.0% reporting it in the previous 12-month period. Tinea pedis was another common condition, affecting 3.6% on our examination day. However, only two-thirds of them (2.4%) recounted a past history of tinea pedis. Scabies was diagnosed among 2.4% of staff and reported as a previous infection by 6.0%. Overall, the prevalence of dermatitis and scabies were quite low when compared to previous studies, while fungal infection rates were similar to other investigations. Further research into this growing occupational demographic is indicated.  (+info)

(8/41) Relation between vesicular eruptions on the hands and tinea pedis, atopic dermatitis and nickel allergy.

The aetiology of vesicular eruptions on the palms and on the sides of the fingers (pompholyx) is unclear. The present study was undertaken to establish whether tinea pedis, atopic dermatitis or nickel allergy is a risk factor for development of vesicular eruptions. Three-hundred-and-ninety-eight individuals (included from an ongoing population study on hand eczema in twins) were included. A history of previous hand eczema and atopic dermatitis was taken, and a clinical examination including a patch test with nickel was performed. A test sample for tinea pedis was taken from the fourth interdigital space on the right foot. The relative risk for vesicular eruptions present in individuals with tinea pedis was 3.58 (confidence limits 1.19-10.82, p < 0.05). For individuals with atopic dermatitis, relative risk was 1.44 (confidence limits 0.34-6.07, n.s.) and for those with nickel allergy it was 0.45 (confidence limits 0.06-3.36, n.s.). A relationship between tinea pedis and vesicular eruptions on the hands was statistically confirmed in the present study. In this part of the population study material, no association with atopic dermatitis or nickel allergy was observed.  (+info)